New Stationary Phases for GC and LC
Pittcon 2009 has brought us back to the windy city, where the technical sessions are sure to be anything but breezy. Sunday afternoon's session titled, "New Stationary Phases for GC and LC," is a prime example of a session that was filled with new information for separation scientists to enjoy.
Pittcon 2009 has brought us back to the windy city, where the technical sessions are sure to be anything but breezy. Sunday afternoon’s session titled, “New Stationary Phases for GC and LC,” is a prime example of a session that was filled with new information for separation scientists to enjoy.
The session began with “Hybrid Mid Polarity Siloxane Stationary Phase Polymers for Next Generation High Performance Capillary GC Columns,” presented by Jack Cochran of Restek Corporation, along with Gary Stidsen, Roy Lautamo, Shawn Reese, Jaap de Zeeuw, Jason Thomas, and Jari Snider.
Following that 20-minute presentation was Allen J. Britten from Cape Breton University and Krishnat P. Naikwadi presenting their findings on “Isomer Specific and High Temperature New Nano Stationary Phase GC Capillary Columns for Fast GC and GC/MS Analysis.”
Third in this session was a presentation titled “LC/MS of Metabolites using a Silica Hydride-Based Stationary Phase.” Joseph Pesek, of San Jose State University, and Maria Matyska presented.
Rounding out this session was Abby Jo Jackson, from the University of Nebraska-Lincoln, along with Hai Xuan, and David S. Hage presenting their findings on “Entrapment of Proteins in Polysaccharide-Capped Hydrazie-Activated Silica Supports for High Performance Affinity.” All-in-all it was a very informative session to start out was is sure to be a great week in Chicago.
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
